Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
New guidance coming soon!
-
Coming soon!! New guidance from PAAB stemming from our global benchmarking initiative.
@Agency @Manufacturer The consultation process for guidance on clinical trials whose duration exceeds that of the pivotal trials in the TMA is winding down. Please stay tuned for the publication of the guidance later this month with projected implementation in April.
We look forward to answering all your questions once we’ve published a guidance.
